Objective Capital Partners Promotes Michael Kim to Managing Director

Posted April 06, 2018 by OCP | Post a Comment

San Diego, April 9, 2018 — Objective Capital Partners is pleased to announce the promotion of Michael Kim to Managing Director. Michael contributes over 15 years of mergers & acquisitions (M&A) and corporate finance experience across numerous industries including technology, consumer, and business services. He was also recognized in 2016 by M&A Advisor as a M&A Advisor Emerging Leaders Award Winner.

Mr Kim joined Objective Capital in 2015 and has been responsible for all aspects of  transaction lifecycle including client sourcing, due diligence, negotiation, valuation analyses, and transaction closings. In his new role, Michael will continue serving the firm’s clients in the areas of transaction origination, analysis and execution.

(more…)

OCP News

Objective Capital's David H. Crean Named 2017 Thought Leader of the Year

Posted January 29, 2018 by OCP | Post a Comment

The Alliance of Merger & Acquisition Advisors® (AM&AA)

San Diego, January 30, 2018 — Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., Managing Director of the firm’s thriving Life Sciences and Healthcare practice, has been selected as the winner of the 2017 Thought Leader of the Year Award by The Alliance of Merger & Acquisition Advisors® (AM&AA).

The AM&AA recognized that “David’s thought leadership is materially expanding the investment banker’s role in serving life sciences companies and providing these companies with a highly attractive, non-diluting alternative to hard-to-secure venture capital financing.”

“We are observing life sciences and healthcare companies increasing engaging specialized investment banking teams with deep industry experience to gain a strategic advantage,” said Trever Acers, Managing Director at Objective Capital Partners.  “Specialized professionals such as David and his team members at Objective Capital are engaged by experienced Life Sciences executives to significantly improve the value, probability and speed of their M&A, strategic partnering, and growth capital objectives.  David is at the forefront of this change, leveraging his decades of industry experience with best-in-class investment banking capabilities to provide CEO with highly actionable strategic guidance."

(more…)

Healthcare, Life Sciences, OCP News, Awards

Community Insights: Understanding Options for Your Business

Posted January 23, 2018 by admin | Post a Comment

San Diego, CA- January 23, 2018 – Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that Trever Acers, a Managing Director at the firm, will be presenting at a series of monthly Community Insights alongside Greg Banner, Vice President at Asset Preservation Strategies. This series of discussions is targeted towards business owners to help them understand planning options for their business. The Community Insights series is designed to introduce estate, financial, business, real estate as well as long-term care planning clients to the various options that facilitate achieving their goals.

There is no cost to attend the Community Insights series but you must register online at:

www.ComIns-BFTandObjCap.com

(more…)

OCP News

Life Sciences Tools, Diagnostics, & Services Industry Report 11/2017

Posted November 14, 2017 by OCP | Post a Comment

Objective Capital Partners has expertise in four industry sectors: Business Services, Consumer, Life Sciences & Healthcare, and Technology. As part of our ongoing efforts in the Life Sciences and Healthcare space, we have developed specific expertise in Life Science Tools. In fact, we recently closed an interesting transaction in the life sciences services space.

(more…)

Healthcare, Life Sciences, OCP News

Bio Buck$ Fast Forward: A Start-up’s Guide to Investment Banks

Posted November 05, 2017 by OCP | Post a Comment

Objective Capital’s David H. Crean to Serve as Guest Panelist at LaunchBio Event, November 14, 2017

San Diego, November 9, 2017 — Objective Capital Partners, a middle market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, has been invited to speak as a guest panelist at LaunchBio Series Event for life science companies entitled BIO Buck$ Fast Forward: A Start-ups Guide to Investment Banks. Dr. Crean will be joined by Charlie Adams, Cantor Fitzgerald and Tony Grover, VP of Business Development at Banyan Biomarker.

(more…)

OCP News, Capital Raise & Financing, Sell-Side M&A

SoCal Capital Summit on M&A Healthcare Trends & Opportunities

Posted November 04, 2017 by OCP | Post a Comment

 

Objective Capital’s David H. Crean to be Guest Panelist at ACG Orange County's CEO Signature Event on November 15, 2017

San Diego, November 6, 2017 — Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, will be a guest panelist speaker at ACG Orange County’s CEO Signature Event entitled SoCal Capital Summit on November 15, 2017.   Dr. Crean and the fellow panelists will address M&A Healthcare Trends and Opportunities.  He will be joined by Greg Cunniff, CFO, NVISION Eye Centers, and Steven Shill, Partner and National Healthcare Practice Leader at BDO.

(more…)

Healthcare, Life Sciences, OCP News, Buy-Side M&A, Sell-Side M&A

Channing Hamlet to Keynote “What’s Your Business Really Worth?”

Posted October 04, 2017 by OCP | Post a Comment

San Diego, CA- October 4, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce that Channing, Hamlet, one of its Managing Directors, will serve as Keynote Speaker as part of the Million Dollar Curriculum on “What’s Your Business Really Worth?”. The program will be held on October 11, 2017 at Corporate Alliance Center, 9171 Towne Centre Drive, San Diego, CA 92122 from 8 AM- 12 PM. The event is sponsored and presented by Cade & Company.

(more…)

OCP News, Sell-Side M&A

NRC Health and Practicing Excellence Form Strategic Alliance

Posted September 19, 2017 by OCP | Post a Comment

Objective Capital Partners Acted as Financial Advisor to Practicing Excellence

San Diego, CA- September 25, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce the successful closing of one of its advisory engagements with Practicing Excellence upon its strategic alliance with and investment from NRC Health. Practicing Excellence, the developer of an online skill-building platform, connects clinicians to practical, evidence-based, colleague-tested tools designed to enhance the delivery of patient care and improve the overall physician experience.

(more…)

Healthcare, Life Sciences, OCP News, Buy-Side M&A, Sell-Side M&A

Weaver Leather, LLC, Acquires Troxel Helmets

Posted August 29, 2017 by OCP | Post a Comment

Objective Capital Partners Acted as Exclusive Financial Advisor to Troxel

San Diego, CA- September 5, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce the successful closing of one of its advisory engagements with Troxel, the world’s leading provider of ASTM/SEI certified equestrian helmets, upon its acquisition by Weaver Leather, LLC. Objective Capital Partners acted as exclusive financial advisor to Troxel.

(more…)

OCP News, Sell-Side M&A, Strategic Advisory

Cagan McAfee Capital Partners Teams with Myles Sherman to Acquire Minimally Invasive Devices

Posted August 16, 2017 by OCP | Post a Comment

Objective Capital Partners Acted as Financial Advisor to MID

 San Diego, CA- August 21, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce the successful closing of one of its advisory engagements with Minimally Invasive Devices (MID), privately-held medical device and market leading laparoscopic surgery solutions company, upon its acquisition by Cagan McAfee Capital Partners and seasoned investor/operator, Myles Sherman of Austin, TX. Objective Capital Partners acted as financial advisors to MID.

(more…)

OCP News

This article is provided for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.

Our Services

Learn about our services and how we can help you sell your business successfully.

LEARN MORE

Contact Us

San Diego Office:
3636 Nobel Dr., Suite 160
San Diego, CA 92122

Los Angeles Office:
10100 Santa Monica Blvd., Suite 300
Los Angeles, CA 90067

Trever Acers
Managing Director
858.663.8662 telephone
trever.acers@objectivecp.com

Channing Hamlet
Managing Director
858.342.4939 telephone
channing.hamlet@objectivecp.com

David H. Crean, Ph.D.
Managing Director
858.461.9490 telephone
david.crean@objectivecp.com

Jack J. Florio
Managing Director
858.864.4339 telephone
jack.florio@objectivecp.com